Seoul – October 12, 2026 -- South Korea's GCCL and LabConnect signed a memorandum of understanding on October 12 to link their North American and Asia-Pacific (APAC) central laboratory capabilities for joint sales and project execution in global clinical trials.

Partners formalize a relationship spanning more than 20 years

The agreement builds on a collaboration that has run for more than 20 years. It aims to improve the operational efficiency of global trial projects by combining each company's regional expertise. Financial terms were not disclosed.

Yongin, South Korea – September 11, 2026 -- GCCL (Global Clinical Central Lab), a South Korea-based clinical trial sample analysis provider, sponsored the Asia Bio Partnering Forum 2026 (ABP 2026) as a Platinum Sponsor, using the Singapore event to pursue expansion of its assay development and clinical sample analysis services across the Asia-Pacific region.

Yongin, South Korea – September 10, 2026 -- GCCL (Global Clinical Central Lab), a South Korea-based clinical trial sample analysis provider, served as a Platinum Sponsor at the Asia Bio Partnering Forum 2026 (ABP 2026) in Singapore, held from August 31 to September 2, as it pursued expansion of its assay development and sample analysis services across the Asia-Pacific region.